Who
William Pao
Director
Company insider
Files Form 4 as: Director, Immunocore Holdings; Executive Vice President, Pfizer.
In numbers
- Trades disclosed
- 8
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 31 Mar 2022
- Last trade
- 27 May 2026
- Last filed
- 28 May 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 27 May 2026filed 28 May 2026 | IMCR Immunocore Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,492 at $0.00 | filing |
| 27 May 2026filed 28 May 2026 | IMCR Immunocore Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,492 at $0.00 | filing |
| 15 May 2025filed 19 May 2025 | IMCR Immunocore Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —26,198 at $0.00 | filing |
| 25 Feb 2025filed 27 Feb 2025 | IMCR Immunocore Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,443 at $0.00 | filing |
| 31 Mar 2023filed 3 Apr 2023 | PFE PfizerPharmaceuticals | SEC FORM 4 Code F | $901K22,095 at $40.80 | filing |
| 23 Feb 2023filed 24 Feb 2023 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —80,360 at $0.00 | filing |
| 23 Feb 2023filed 24 Feb 2023 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —69,938 at $0.00 | filing |
| 31 Mar 2022filed 1 Apr 2022 | PFE PfizerPharmaceuticals | SEC FORM 4 Code A | —115,897 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.